Terns Pharmaceuticals (TERN) Q4 2022 Earnings

27MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.64
-0.52
-0.41
-0.29

Details

Expected EPS
-0.43
Actual EPS
-0.29
Surprise EPS
0.14
Surprise Percent
+32.56%

Description

Terns Pharmaceuticals (TERN) has reported earnings of -0.29 per share for Q4 2022.

0 Comments

Share your thoughts